No headlines found.
Precipio Secures a short-term $500K Credit Facility
Globe Newswire (Mon, 6-May 5:00 PM ET)
Precipio Announces Year end 2023 Shareholder Update Call
Globe Newswire (Mon, 25-Mar 5:00 PM ET)
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Precipio trades on the NASDAQ stock market under the symbol PRPO.
As of May 16, 2024, PRPO stock price declined to $6.21 with 5,763 million shares trading.
PRPO has a market cap of $8.82 million. This is considered a Sub-Micro Cap stock.
Last quarter Precipio reported $3 million in Revenue and -$1.46 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.76.
In the last 3 years, PRPO stock traded as high as $106.00 and as low as $4.75.
The top ETF exchange traded funds that PRPO belongs to (by Net Assets): VXF, VTI.
PRPO has underperformed the market in the last year with a return of -47.9%, while the SPY ETF gained +29.6%. In the last 3 month period, PRPO fell short of the market, returning -6.6%, while SPY returned +5.6%. However, in the most recent 2 weeks PRPO has outperformed the stock market by returning +10.5%, while SPY returned +5.7%.
PRPO support price is $5.88 and resistance is $6.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRPO stock will trade within this expected range on the day.